Glaukos (GKOS) Return on Capital Employed (2015 - 2026)
Glaukos (GKOS) reported Return on Capital Employed of 4.94% for Q1 2026, down 359.0% year-over-year from 1.91% in Q1 2025, and down 2.99% quarter-over-quarter from 4.8% in Q4 2025.
Glaukos (GKOS) Return on Capital Employed (2015 - 2026) Analysis & Trends
Glaukos (GKOS) has 12 years of Return on Capital Employed data on file, last reported at 4.94% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 4.94%, down 359.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.94% (down 359.0% YoY), and the FY2025 annual result was 4.87%, down 140.0% from the prior year.
- Return on Capital Employed retreated to 4.94% in Q1 2026 per GKOS's latest filing, from 4.8% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 0.37% in Q3 2025 and troughed at 15.84% in Q2 2024.
- A 5-year average of 8.08% and a median of 6.93% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed slumped 1239 bps in 2023, then jumped 1592 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 8.82% in 2022, then slumped by 68 bps to 14.78% in 2023, then jumped by 76 bps to 3.49% in 2024, then plunged by 37 bps to 4.8% in 2025, then fell by 3 bps to 4.94% in 2026.
- Business Quant data shows GKOS's Return on Capital Employed at 4.94% in Q1 2026, 4.8% in Q4 2025, and 0.37% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Glaukos | 7.55 Bn | 7.45 Bn | 117.23 Mn | -4.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.94% |
| Dec 31, 2025 | -4.80% |
| Sep 30, 2025 | 0.37% |
| Jun 30, 2025 | -0.55% |
| Mar 31, 2025 | -1.35% |
| Dec 31, 2024 | -3.49% |
| Sep 30, 2024 | -15.54% |
| Jun 30, 2024 | -15.84% |
| Mar 31, 2024 | -15.59% |
| Dec 31, 2023 | -14.78% |
| Sep 30, 2023 | -13.98% |
| Jun 30, 2023 | -13.03% |
| Mar 31, 2023 | -13.52% |
| Dec 31, 2022 | -8.82% |
| Sep 30, 2022 | -6.93% |
| Jun 30, 2022 | -3.48% |
| Mar 31, 2022 | -1.13% |
| Dec 31, 2021 | -3.31% |
| Sep 30, 2021 | -2.66% |
| Jun 30, 2021 | -7.28% |